Dermal filler marketing: how to attract the patient you want

Dermal fillers have a problem no other aesthetic treatment has: everyone has seen a bad result. They circulate on social media, they get discussed, they turn up on television. Anybody considering treatment arrives carrying that image, and their first question is not what it costs. It is whether it will be obvious.

That makes filler marketing an exercise in filtering rather than volume. Two very different buyers are searching the same terms, and your messaging decides which one walks through your door.

The two buyers

The one who wants it invisible. Looking for hydration, definition, correction of an asymmetry, restoration of volume lost with age. Their fear is excess. They return every nine to twelve months, they refer, and they almost never complain.

The one who wants obvious volume. Arrives with a reference photo, asks for more than the anatomy supports, and compares clinics by who will inject the most. This is the patient who produces the result that circulates, who complains, and who leaves for the next practice when you say no.

No serious practice wants the second, yet most industry marketing attracts them directly: close-up lip photography, per-syringe promotions and volume-led messaging.

The messaging that filters does the opposite. Talk about proportion, anatomy and the goal of nobody knowing you had anything done. Fewer clicks, far better patients.

Saying no is a marketing strategy

It sounds counterintuitive, but declining treatment is one of the strongest communication assets a practice has here.

Publishing, openly, when you would not add more filler, what happens when an area is already saturated, and why the right answer is sometimes to dissolve before refilling, does two things. The patient who wants natural results recognises immediately that they have found the right place. The patient who wants excess disqualifies themselves, saving you a consultation that was never going to end well.

Reversibility is your best argument and nobody uses it

That hyaluronic acid can be dissolved is, to a frightened prospect, the single most reassuring fact available. It rarely appears in practice marketing, presumably out of concern that it implies something might go wrong.

The effect is the opposite of what is feared. A practice that explains reversibility calmly — what it involves, when it is considered, what it costs — signals control and honesty. It is exactly the kind of content a prospect forwards to whoever is advising them.

Advertising: the most restricted ground in aesthetics

Fillers are regulated medical devices, and their promotion to the public is constrained in most markets. Layered on top, advertising platforms are especially restrictive with this treatment. Meta routinely rejects creatives showing close-up lips or faces with the treatment area marked, and before-and-after imagery is prohibited under body image policies rather than only by health regulation.

What passes and performs: informational content, video of the injector explaining how they assess a face, and patient testimony describing their experience without visual comparison. Slower to produce and much harder for a competitor to copy.

The syringe pricing trap

Almost every practice prices per syringe. The problem is that a prospect has no idea how many they need, so the figure does not help them budget — it only helps them compare practices against each other. The result is a race to the bottom that erodes margin without improving patient quality.

The alternative that works is pricing by outcome: what one syringe achieves, what changes with two, and when it makes sense to split treatment across sessions. More writing effort, and it filters out the syringe shopper, who is exactly the patient who does not return and generates the most complaints.

The consultation is the product

With fillers, the sale does not happen on the website. It happens in the consultation. The website has one job: to get that consultation booked with expectations already calibrated.

That changes what the page needs. Not persuasion about the treatment, but clarity about the consultation itself: how long it takes, whether you can be treated the same day, whether there is a fee and whether it is credited. Missing that information is the number one reason a decided prospect does not book.

What to measure

• Consultations booked per month by area of interest, not in total.
• Share treated same-day versus those who go away to think.
• Return rate at twelve months, since the filler cycle is longer than neurotoxin and needs that window.
• Dissolution and touch-up rate, which is your real quality indicator.
• Reason for not treating, logged with fixed categories including declined on clinical judgement. That third category should exist and almost never does.

The mistakes that cost most

• Lip close-ups in advertising. Rejected by platforms, and when they run they attract the wrong buyer.
• Syringe bundle promotions. Turn a clinical decision into a volume purchase and invite regulatory attention.
• Silence about complications. The informed prospect goes looking, and finds the answer wherever someone is willing to give it.
• Same-day treatment for someone arriving with an extreme reference photo. This is where most bad outcomes originate.
• No review appointment. Minor asymmetry is normal and fixed in five minutes; without a review it becomes a one-star notice.

When the result is not what they wanted

It will happen. In a small share of cases the patient is unhappy, and how that is handled determines whether they write a one-star review or come back next year.

Practices that handle it well decide three things in advance: a no-charge review window, a clear policy on when product is dissolved and who bears that cost, and a designated person for that conversation who is not the injector. Having it written down prevents defensive improvisation, which is what turns an unhappy patient into a public problem.

It is also worth being explicit internally about the difference between a technical complication and an expectation mismatch. They feel the same to the patient and require completely different responses.

Referring out to surgery

Some prospects are not filler candidates and need surgery. Telling them costs one treatment and buys something more valuable: the certainty that you do not sell for the sake of selling.

If you have a relationship with a plastic surgeon, that referral runs in both directions, and surgeons regularly send back the cases that do not justify an operating room along with post-surgical refinements. Those are high-value patients arriving pre-qualified.

In your marketing, stating openly that there are cases where you would not recommend treatment is among the strongest trust signals available in this category, precisely because so few practices are willing to say it.

Where to start

Write the "will it look obvious" page first. It is the parent search and almost nobody answers it honestly. Then the reversibility page, which unlocks the frightened prospect.

And make the three-week review a fixed protocol. In a treatment where reputation is everything, catching dissatisfaction before it is published is worth more than any campaign.

Frequently asked questions

How do you avoid attracting patients who want excessive volume?

By leading with proportion and natural results rather than volume, and by publishing openly when you would decline to add more filler. That content generates fewer clicks but filters: the patient seeking excess disqualifies themselves.

Can med spas use before-and-after filler photos in ads?

Advertising platforms prohibit them under body image policies, separately from health regulation, and routinely reject lip close-ups. Video of the injector explaining their assessment approach passes and converts better.

Why is per-syringe pricing a problem?

Because prospects do not know how many they need, so the number only helps them compare practices on price. Pricing by outcome — what one syringe achieves, what two change — filters out syringe shoppers and protects margin.

Why does reversibility belong in the marketing?

It is the single most reassuring fact for a frightened prospect, which is the majority of this market. Explaining it calmly signals control and honesty, and it is the content prospects forward to whoever is advising them.